Chi‐Chung Chan

7.5k total citations
41 papers, 2.7k citations indexed

About

Chi‐Chung Chan is a scholar working on Pharmacology, Molecular Biology and Physiology. According to data from OpenAlex, Chi‐Chung Chan has authored 41 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 13 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Chi‐Chung Chan's work include Inflammatory mediators and NSAID effects (11 papers), Asthma and respiratory diseases (8 papers) and Estrogen and related hormone effects (7 papers). Chi‐Chung Chan is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Asthma and respiratory diseases (8 papers) and Estrogen and related hormone effects (7 papers). Chi‐Chung Chan collaborates with scholars based in Canada, United States and Hong Kong. Chi‐Chung Chan's co-authors include Christine Brideau, Robert J. Gordon, Jocelyne Guay, Denis Riendeau, Joseph A. Mancini, Ian W. Rodger, Panagiota B. Stamatiou, David Claveau, Zheng Huang and Annette Robichaud and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Chi‐Chung Chan

41 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Chung Chan Canada 25 1.2k 1.0k 709 378 377 41 2.7k
S. Charleson Canada 25 1.0k 0.8× 770 0.8× 505 0.7× 325 0.9× 791 2.1× 51 2.7k
Jocelyne Guay Canada 25 1.1k 0.9× 886 0.9× 786 1.1× 135 0.4× 237 0.6× 42 2.5k
Danielle Denis Canada 24 825 0.7× 597 0.6× 478 0.7× 152 0.4× 451 1.2× 37 2.0k
Sharon Sadowski United States 27 619 0.5× 1.5k 1.5× 501 0.7× 405 1.1× 519 1.4× 57 3.2k
Sabine Grösch Germany 42 1.3k 1.1× 2.8k 2.8× 459 0.6× 505 1.3× 619 1.6× 84 5.2k
Robert Zamboni Canada 35 459 0.4× 2.0k 2.0× 1.2k 1.7× 425 1.1× 989 2.6× 110 4.2k
Aaron B. Miller United States 26 521 0.4× 1.5k 1.4× 543 0.8× 73 0.2× 199 0.5× 47 2.8k
F.A. Fitzpatrick United States 22 513 0.4× 1.2k 1.2× 144 0.2× 255 0.7× 289 0.8× 34 2.4k
Tsumoru Miyamoto Japan 16 670 0.5× 489 0.5× 183 0.3× 166 0.4× 297 0.8× 22 1.7k
David Haigh United Kingdom 28 243 0.2× 1.8k 1.8× 1.1k 1.5× 125 0.3× 222 0.6× 53 3.1k

Countries citing papers authored by Chi‐Chung Chan

Since Specialization
Citations

This map shows the geographic impact of Chi‐Chung Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Chung Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Chung Chan more than expected).

Fields of papers citing papers by Chi‐Chung Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Chung Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Chung Chan. The network helps show where Chi‐Chung Chan may publish in the future.

Co-authorship network of co-authors of Chi‐Chung Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Chung Chan. A scholar is included among the top collaborators of Chi‐Chung Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Chung Chan. Chi‐Chung Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landry, France, Chi‐Chung Chan, Zheng Huang, et al.. (2011). Plasma-based approach to measure target engagement for liver-targeting stearoyl-CoA desaturase 1 inhibitors. Journal of Lipid Research. 52(8). 1494–1499. 10 indexed citations
2.
Powell, David, W. Cameron Black, Kelly Bleasby, et al.. (2011). Nicotinic acids: Liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy. Bioorganic & Medicinal Chemistry Letters. 21(24). 7281–7286. 15 indexed citations
3.
Isabel, Élise, David Powell, W. Cameron Black, et al.. (2010). Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(1). 479–483. 24 indexed citations
4.
Han, Yongxin, Michel Belley, Christopher I. Bayly, et al.. (2008). Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitor. Bioorganic & Medicinal Chemistry Letters. 18(11). 3200–3205. 50 indexed citations
5.
Clark, Patsy, Robert J. Gordon, Jocelyne Guay, et al.. (2007). Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species. European Journal of Pharmacology. 560(2-3). 216–224. 12 indexed citations
6.
Grimm, Erich L., Christine Brideau, Nathalie Chauret, et al.. (2006). Substituted coumarins as potent 5-lipoxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(9). 2528–2531. 44 indexed citations
7.
MacDonald, Ian M., et al.. (2005). REP–1 Localization in the Eye. Investigative Ophthalmology & Visual Science. 46(13). 540–540. 3 indexed citations
8.
Stamatiou, Panagiota B., Chi‐Chung Chan, Guillaume Monneret, et al.. (2004). 5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates the Release of the Eosinophil Survival Factor Granulocyte/Macrophage Colony-stimulating Factor from Monocytes. Journal of Biological Chemistry. 279(27). 28159–28164. 26 indexed citations
9.
10.
Robichaud, Annette, Panagiota B. Stamatiou, S.-L. Catherine Jin, et al.. (2002). Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor–mediated anesthesia, a behavioral correlate of emesis. Journal of Clinical Investigation. 110(7). 1045–1052. 24 indexed citations
11.
Robichaud, Annette, Panagiota B. Stamatiou, S.-L. Catherine Jin, et al.. (2002). Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor–mediated anesthesia, a behavioral correlate of emesis. Journal of Clinical Investigation. 110(7). 1045–1052. 238 indexed citations
12.
Xu, Hui, Gideon Strassmann, Chi‐Chung Chan, et al.. (1999). Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.. PubMed. 40(5). 942–50. 15 indexed citations
13.
Brideau, Christine, Carlo van Staden, Angela Styhler, Ian W. Rodger, & Chi‐Chung Chan. (1999). The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor‐α and leukotriene B4 in a novel human whole blood assay. British Journal of Pharmacology. 126(4). 979–988. 60 indexed citations
14.
Dubé, Daniel, Christine Brideau, Denis Deschênes, et al.. (1999). 2-Heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(12). 1715–1720. 22 indexed citations
15.
Dubé, Daniel, Marc Blouin, Christine Brideau, et al.. (1998). Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530. Bioorganic & Medicinal Chemistry Letters. 8(10). 1255–1260. 244 indexed citations
16.
Brideau, Christine, Stacia Kargman, Aimée Dallob, et al.. (1996). A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflammation Research. 45(2). 68–74. 241 indexed citations
17.
Lai, J. C. K., et al.. (1995). Intraocular inflammation in transgenic mice expressing a foreign antigen in their lens a preliminary report. Ocular Immunology and Inflammation. 3(2). 59–62. 1 indexed citations
18.
19.
Rizzo, Luiz Vicente, et al.. (1994). Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity.. Journal of Clinical Investigation. 94(4). 1668–1672. 92 indexed citations
20.
Riendeau, Denis, et al.. (1991). Inhibition of leukotriene B4 biosynthesis by disulfiram and A-64077 during carrageenan-induced pleurisy in the rat. General Pharmacology The Vascular System. 22(2). 371–374. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Charleson Breakdown of academic impact, for papers by Jocelyne Guay Breakdown of academic impact, for papers by Danielle Denis Breakdown of academic impact, for papers by Sharon Sadowski Breakdown of academic impact, for papers by Sabine Grösch Breakdown of academic impact, for papers by Robert Zamboni Breakdown of academic impact, for papers by Aaron B. Miller Breakdown of academic impact, for papers by F.A. Fitzpatrick Breakdown of academic impact, for papers by Tsumoru Miyamoto Breakdown of academic impact, for papers by David Haigh
Rankless by CCL
2026